Insider filing · BCAX
Ivan Hyep
Chief Financial Officer
profile →
Bicara Therapeutics Inc.
BCAX · Healthcare · 40 filings in 24 months
ticker →
Ivan Hyep sold $330K of Bicara Therapeutics (BCAX)
Executed Nov 24 2025, disclosed Nov 25 2025, 1 day later.
Value, as filed
$330K
17,795 sh × $18.55
Executed
Nov 24 2025
the trade date, as filed
Disclosed
Nov 25 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
IHIvan Hyep (Chief Financial Officer) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $783K of BCAX (27,170 sh across 2 lots, as filed), executed Jul 8.
The name
BCAXHealthcare · Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Ivan Hyep in BCAX
BCAXSALE
Bicara Therapeutics Inc.
$350K12,500 sh × $27.97
Exec Aug 10
Filed Aug 12 · 4:19 PM ET BCAXSALE Bicara Therapeutics Inc. $783K
27,170 sh across 2 lots
Exec Jul 8
Filed Jul 10 · 4:10 PM ET BCAXSALE Bicara Therapeutics Inc. $188K
9,200 sh × $20.42
Exec May 21
Filed May 26 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $212K
9,200 sh × $23.00
Exec Apr 21
Filed Apr 22 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $170K
9,200 sh × $18.52
Exec Mar 23
Filed Mar 24 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $247K
13,555 sh × $18.22
Exec Mar 3
Filed Mar 5 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $168K
9,200 sh × $18.31
Exec Dec 22 2025
Filed Dec 23 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $117K
6,415 sh × $18.23
Exec Oct 9 2025
Filed Oct 10 2025 · 5:30 PM ET